NCT06625957

Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition

A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 Versus NTCB-C in Patients Who Require Parenteral Nutrition

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Yuhan Corporation · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 versus NTCB-C in patients who require parenteral nutrition

Conditions

• Parenteral Nutrition

Interventions

Type	Name	Description
DRUG	NTCB02-1	3 Days infusion
DRUG	NTCB-C	3 Days infusion

Timeline

• Start date: 2024-12-04
• Primary completion: 2025-07-18
• Completion: 2025-07-18
• First posted: 2024-10-03
• Last updated: 2025-01-07

Locations

5 sites across 1 country: South Korea